The book provides a comprehensive and forward-looking exploration of the technologies, processes, and innovations that are reshaping the production of biologics and biopharmaceuticals through advanced biomanufacturing.
Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients.
Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecycle―from early-stage development to commercial-scale production―and tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation.
Readers will find the volume:
Audience
This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Sandip Kunar, PhD is an Associate Professor in the Department of Mechanical Engineering, Aditya University, Surampalem, Andhra Pradesh, India. He has published more than 60 research papers in various reputed international journals and conference proceedings, 60 book chapters, 20 books, and one patent. His research interests include non-conventional machining processes, micromachining processes, biomanufacturing, advanced manufacturing technology, and industrial engineering.
Jagadeesha T., PhD is an Associate Professor in the Mechanical Engineering Department, the National Institute of Technology Calicut, Kerala, India, with more than 25 years of experience. He has developed workbooks and has four patents and more than 75 publications in international journals and conferences. His research interests are advanced machining, additive manufacturing, fluid power control, advanced materials, and vibration and noise control.
D. Sathis Kumar, PhD is the Principal of Aditya Pharmacy College, Surampalem, Andhra Pradesh, India. He has published 54 research articles in esteemed national and international journals, presented papers at reputed conferences, and authored one book. His primary research areas include analytical method development, statistical optimization using software tools, green analytical chemistry, phytochemical analysis, and quality control studies.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. The book provides a comprehensive and forward-looking exploration of the technologies, processes, and innovations that are reshaping the production of biologics and biopharmaceuticals through advanced biomanufacturing. Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients. Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecyclefrom early-stage development to commercial-scale productionand tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation. Readers will find the volume: Explores the latest technologies driving efficiency and innovation in biologics production, including continuous manufacturing and single-use systems;Features expert insights from industry leaders, researchers, and regulatory professionals shaping the future of biomanufacturing;Covers key regulatory, scalability, and quality challenges with real-world case studies and solutions;Bridges academic and industrial perspectives, making it a valuable resource for both newcomers and seasoned professionals. Audience This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781394440511
Quantité disponible : 1 disponible(s)
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-Uni
Hardback. Etat : New. The book provides a comprehensive and forward-looking exploration of the technologies, processes, and innovations that are reshaping the production of biologics and biopharmaceuticals through advanced biomanufacturing. Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients. Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecycle-from early-stage development to commercial-scale production-and tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation. Readers will find the volume: Explores the latest technologies driving efficiency and innovation in biologics production, including continuous manufacturing and single-use systems;Features expert insights from industry leaders, researchers, and regulatory professionals shaping the future of biomanufacturing;Covers key regulatory, scalability, and quality challenges with real-world case studies and solutions;Bridges academic and industrial perspectives, making it a valuable resource for both newcomers and seasoned professionals. Audience This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals. N° de réf. du vendeur LU-9781394440511
Quantité disponible : 5 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Hardcover. Etat : new. Hardcover. The book provides a comprehensive and forward-looking exploration of the technologies, processes, and innovations that are reshaping the production of biologics and biopharmaceuticals through advanced biomanufacturing. Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients. Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecyclefrom early-stage development to commercial-scale productionand tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation. Readers will find the volume: Explores the latest technologies driving efficiency and innovation in biologics production, including continuous manufacturing and single-use systems;Features expert insights from industry leaders, researchers, and regulatory professionals shaping the future of biomanufacturing;Covers key regulatory, scalability, and quality challenges with real-world case studies and solutions;Bridges academic and industrial perspectives, making it a valuable resource for both newcomers and seasoned professionals. Audience This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9781394440511
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. N° de réf. du vendeur 408571758
Quantité disponible : 3 disponible(s)
Vendeur : Rarewaves.com UK, London, Royaume-Uni
Hardback. Etat : New. The book provides a comprehensive and forward-looking exploration of the technologies, processes, and innovations that are reshaping the production of biologics and biopharmaceuticals through advanced biomanufacturing. Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients. Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecycle-from early-stage development to commercial-scale production-and tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation. Readers will find the volume: Explores the latest technologies driving efficiency and innovation in biologics production, including continuous manufacturing and single-use systems;Features expert insights from industry leaders, researchers, and regulatory professionals shaping the future of biomanufacturing;Covers key regulatory, scalability, and quality challenges with real-world case studies and solutions;Bridges academic and industrial perspectives, making it a valuable resource for both newcomers and seasoned professionals. Audience This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals. N° de réf. du vendeur LU-9781394440511
Quantité disponible : 5 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26405663921
Quantité disponible : 3 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Hardcover. Etat : Brand New. 1024 pages. 9.45x1.77x6.30 inches. In Stock. N° de réf. du vendeur __1394440510
Quantité disponible : 2 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Hardcover. Etat : new. Hardcover. The book provides a comprehensive and forward-looking exploration of the technologies, processes, and innovations that are reshaping the production of biologics and biopharmaceuticals through advanced biomanufacturing. Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients. Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecyclefrom early-stage development to commercial-scale productionand tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation. Readers will find the volume: Explores the latest technologies driving efficiency and innovation in biologics production, including continuous manufacturing and single-use systems;Features expert insights from industry leaders, researchers, and regulatory professionals shaping the future of biomanufacturing;Covers key regulatory, scalability, and quality challenges with real-world case studies and solutions;Bridges academic and industrial perspectives, making it a valuable resource for both newcomers and seasoned professionals. Audience This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9781394440511
Quantité disponible : 1 disponible(s)
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
Etat : New. 2026. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland. N° de réf. du vendeur V9781394440511
Quantité disponible : 1 disponible(s)
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Etat : New. 2026. 1st Edition. hardcover. . . . . . N° de réf. du vendeur V9781394440511
Quantité disponible : 1 disponible(s)